April 3, 2021 Comments Off on New patent for Esperion Theraps drug NEXLIZET Posted in: Patent Added Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are five patents protecting this drug. NEXLIZET drug…
The post New patent for Esperion Theraps drug NEXLIZET appeared firs…
April 3, 2021 Comments Off on New patent for Pfizer drug LORBRENA Posted in: Patent Added Annual Drug Patent Expirations for LORBRENA Lorbrena is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Pfizer drug LORBRENA appeared first on DrugPatent…
